SDPS-46 CENTRAL NERVOUS SYSTEM (CNS)-RELATED MORTALITY IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER

BACKGROUND: Approximately one third of patients with HER2-positive (+) metastatic breast cancer (MBC) develop brain metastases (BrM). In light of discordant control of extracranial metastases (ECM) versus BrM for standard-of-care antibody-based therapies for these patients, and the frequent use of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraro, Emanuela, Nassif, Rabih Bou, Reiner, Anne, Tosi, Umberto, Panageas, Katherine, Dang, Chau T, Seidman, Andrew D, Moss, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402311/
http://dx.doi.org/10.1093/noajnl/vdad070.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402311/
http://dx.doi.org/10.1093/noajnl/vdad070.100

Ejemplares similares